Search Results - "Coats, Michael E."
-
1
Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis
Published in Multiple sclerosis (01-08-2005)“…An open-label extension study of the phase III trial of intramuscular interferon beta-1a (IFNβ-1a-Avonex) was conducted to evaluate the immunogenicity and…”
Get full text
Journal Article -
2
Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis
Published in Journal of neuroimmunology (1999)“…Background and objective: This report provides results of CSF analyses done in a subset of relapsing remitting MS patients participating in a…”
Get full text
Journal Article -
3
Eight-year immunogenicity and safety of interferon beta-la-avonex® treatment in patients with multiple sclerosis
Published in Multiple sclerosis (2005)Get full text
Journal Article -
4
Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis1Studies supported by the National Multiple Sclerosis Society (grants RG2019, RG2827); the NINDS (NS26321); and Biogen Inc.1
Published in Journal of neuroimmunology (01-01-1999)Get full text
Journal Article -
5
Meige's disease and a positive treatment response with deanol
Published in Military medicine (01-03-1985)Get more information
Journal Article